Li Jieyun, Seetoh Wei Song, Lim Jiekee, Xiao Xin'ang, Yang Kehu, Yeo Si Yong, Sun Boyun, Liu Jinhua, Xu Zhaoxia, Zhong Linda L D
School of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Shanghai Key Laboratory of Health Identification and Assessment, Shanghai, China.
Front Digit Health. 2025 May 16;7:1575320. doi: 10.3389/fdgth.2025.1575320. eCollection 2025.
The application of artificial intelligence in diagnostic prediction models for diseases and syndromes in Chinese Medicine (CM) has been rapidly expanding, accompanied by a significant increase in related research publications. However, existing reporting guidelines for diagnostic prediction models are primarily tailored to Western medicine, which differs fundamentally from CM in its theoretical framework, terminology, and classification systems. To address this gap, it is essential to establish a transparent and standardized reporting tool specifically designed for CM diagnostic and syndrome prediction models. This will enhance the transparency, reproducibility, and clinical relevance of research findings in this emerging field.
This study adopts a structured, multi-phase Delphi protocol. A core working group will first conduct a comprehensive review of published studies on CM diagnostic prediction models to develop an initial item pool for the Transparent Reporting Tool for AI-based Diagnostic Prediction Models of Disease and Syndrome in Chinese Medicine (TRAPODS-CM). Delphi questionnaires will then be distributed via email to a multidisciplinary panel of experts in CM, computer science, and evidence-based methodology who meet the inclusion criteria. The number of Delphi rounds will be determined by evaluating the active coefficient, expert authority, and expert consensus. Final consensus on the TRAPODS-CM checklist will be achieved through online meetings. The study will be governed by a Steering Committee, with the core working group responsible for implementation. After publication, the finalized checklist will be disseminated via multimedia platforms, seminars, and academic conferences to maximize its academic and clinical impact.
This project has received ethical approval from the National Natural Science Foundation of China (Grant No. 82374336) and the Institutional Review Board of Nanyang Technological University (IRB-2024-1007). The study findings will be disseminated through peer-reviewed publications.
人工智能在中医疾病和证候诊断预测模型中的应用正在迅速扩展,相关研究出版物也显著增加。然而,现有的诊断预测模型报告指南主要是针对西医的,其理论框架、术语和分类系统与中医有根本区别。为弥补这一差距,建立一个专门为中医诊断和证候预测模型设计的透明、标准化报告工具至关重要。这将提高这一新兴领域研究结果的透明度、可重复性和临床相关性。
本研究采用结构化的多阶段德尔菲协议。一个核心工作组将首先对已发表的中医诊断预测模型研究进行全面综述,以制定《中医基于人工智能的疾病和证候诊断预测模型透明报告工具》(TRAPODS-CM)的初始条目池。然后,德尔菲问卷将通过电子邮件分发给符合纳入标准的中医、计算机科学和循证方法多学科专家小组。德尔菲轮次的数量将通过评估积极系数、专家权威和专家共识来确定。通过在线会议达成对TRAPODS-CM清单的最终共识。该研究将由一个指导委员会管理,核心工作组负责实施。清单定稿后将通过多媒体平台、研讨会和学术会议进行传播,以最大限度地扩大其学术和临床影响。
本项目已获得中国国家自然科学基金(批准号8237~4336)和南洋理工大学机构审查委员会(IRB-2024-1007)的伦理批准。研究结果将通过同行评审出版物进行传播。